Showing results (211-220 of 224) with videos related to
Sort By:
Pageof 23
Journal of Cancer Survivorship : Research and Practice|December 8, 2019
Developing the structure of Japan's cancer survivorship guidelines using an expert panel and modified Delphi methodYutaka J Matsuoka, Ryo Okubo, Yoichi Shimizu, et al.The Lancet. Oncology|December 9, 2022
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trialStephen R D Johnston, Masakazu Toi, Joyce O'Shaughnessy, et al.International Journal of Clinical Oncology|September 4, 2024
Out-of-pocket fertility preservation expenses: data from a Japanese nationwide multicenter surveyMasanori Ono, Yasushi Takai, Miyuki Harada, et al.Cancer Science|February 11, 2025
Germline Pathogenic Variants and Clinical Outcomes in Asian Patients With Breast CancerRui Kitadai, Shu Yazaki, Aya Kuchiba, et al.Breast (Edinburgh, Scotland)|August 14, 2021
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancyAnn H Partridge, Samuel M Niman, Monica Ruggeri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2025
Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE TrialFedro A Peccatori, Samuel M Niman, Ann H Partridge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2024
Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt PregnancyHatem A Azim, Samuel M Niman, Ann H Partridge, et al.Breast (Edinburgh, Scotland)|July 31, 2025
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trialIsabelle Demeestere, Samuel M Niman, Ann H Partridge, et al.The New England Journal of Medicine|May 3, 2023
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast CancerAnn H Partridge, Samuel M Niman, Monica Ruggeri, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2026
Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) TrialOlivia Pagani, Samuel M Niman, Monica Ruggeri, et al.Pageof 23